Cytodyn Inc. (CYDY) — 10-Q Filings
All 10-Q filings from Cytodyn Inc.. Browse 7 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (7)
-
CytoDyn Inc. Files Q1 2026 10-Q Report
— Apr 8, 2026 Risk: low
CytoDyn Inc. filed its quarterly report (10-Q) on April 8, 2026, for the period ending February 28, 2026. The filing includes various exhibits such as the 10-Q -
CytoDyn's Net Loss Widens to $5.54M Amid R&D Spend, Cash Drains
— Oct 10, 2025 Risk: high
CytoDyn Inc. reported a net loss of $5.54 million for the three months ended August 31, 2025, a significant decline from the net income of $19.23 million in the -
CytoDyn Inc. Files 10-Q for Period Ending Feb 28, 2025
— Apr 14, 2025 Risk: medium
CytoDyn Inc. filed its 10-Q for the period ending February 28, 2025. The company's fiscal year ends on May 31st. Key financial data points and disclosures relat -
CytoDyn Inc. Files 10-Q for Nov 30, 2024
— Jan 14, 2025 Risk: medium
CytoDyn Inc. filed its 10-Q for the period ending November 30, 2024. The company reported financial results and operational updates. Specific financial figures -
CytoDyn Inc. Files Q2 2024 10-Q with Financial Updates
— Oct 15, 2024 Risk: medium
CytoDyn Inc. filed its 10-Q for the period ending August 31, 2024. The company's fiscal year ends May 31st. Key financial data points such as common stock, reta -
CytoDyn Inc. Files 10-Q for Period Ending February 29, 2024
— Apr 15, 2024 Risk: medium
CytoDyn Inc. (CYDY) filed a Quarterly Report (10-Q) with the SEC on April 15, 2024. CytoDyn Inc. reported financial results for the period ending February 29, 2 -
CytoDyn Inc. Files 10-Q for Period Ending November 30, 2023
— Jan 16, 2024 Risk: medium
CytoDyn Inc. (CYDY) filed a Quarterly Report (10-Q) with the SEC on January 16, 2024. CytoDyn Inc. filed a 10-Q report for the period ending November 30, 2023.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX